IMMUNOPHENOTYPIC PROFILE AND FUNCTIONAL CHARACTERISTICS OF NK CELLS EXPANDED FROM CYTOMEGALOVIRUS SEROPOSITIVE AND SERONEGATIVE DONORS: IMPLICATIONS FOR NEW STRATEGIES OF ADOPTIVE CELLULAR THERAPIES

EHA Library, Nadia Peragine, 53575

HYPOMETHYLATING AGENT AZACITIDINE INDUCES FOXP3 NEGATIVE HLA-G EXPRESSING IMMUNOREGULATORY T CELLS.

EHA Library, MARIA LIGA, 53574

CLINICAL OUTCOME AND PROGNOSIS IN PATIENTS WITH PRIMARY SINONASAL TRACT DIFFUSE LARGE B CELL LYMPHOMA TREATED WITH R-CHOP CHEMOTHERAPY: MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Gyeong-Won Lee, 54413

AN EFFICIENT AND COST EFFECTIVE METHOD FOR THE GENERATION OF CLINICALLY RELEVANT NUMBERS OF MYELOID CORD BLOOD-DERIVED DENDRITIC CELLS BY EMPLOYING CLINICALLY APPROVED AGENTS

EHA Library, Panayotis Kaloyannidis, 53573

THE ROLE OF IMAGE GUIDED CORE BIOPSY IN THE DIAGNOSIS OF HAEMATOLOGICAL MALIGNANCY

EHA Library, Katharine Bailey, 54412

DESIGNING TCR SPECIFIC FOR HUMAN MDM2 TUMOR-ASSOCIATED ANTIGEN FOR ADOPTIVE IMMUNOTHERAPY AGAINST MELANOMA AND MULTIPLE MYELOMA

EHA Library, Eva Amann, 53572

EVALUATION OF THE NOVEL, ORALLY BIOAVAILABLE SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) VERDINEXOR (KPT-335) IN SPONTANEOUS CANINE CANCERS: RESULTS OF PHASE I AND PHASE II CLINICAL TRIALS

EHA Library, CHRISTINE CHEN, 54411

CYTOMEGALOVIRUS-SPECIFIC CYTOTOXIC T LYMPHOCYTES RESTRICTED TO HLA-A2 OR HLA-A24 CAN BE EFFICIENTLY GENERATED BY USING GENE-ENGINEERED ARTIFICIAL ANTIGEN-PRESENTING CELLS

EHA Library, Masahiro Ogasawara, 53571

TORISEL IN MANTLE CELL LYMPHOMA: RESULTS OF RESTOR STUDY (NON INTERVENTIONAL, LONGITUDINAL, RETROSPECTIVE, MULTICENTER AND NATIONAL STUDY ON A COHORT OF 93 PATIENTS WITH MANTLE CELL LYMPHOMA)

EHA Library, Kamal Bouabdallah, 54410

ADOPTIVE CIK CELLS IN PATIENTS WITH LEUKEMIA RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Qing Li, 53570

MONOCLONAL AND POLYCLONAL GAMMOPATHY MEASURED BY SERUM FREE LIGHT CHAIN AND IMMUNOFIXATION SUBDIVIDE THE CLINICAL OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA ACCORDING TO MOLECULAR CLASSIFICATION

EHA Library, Yu Ri Kim, 54409

HDAC6 INHIBITION AUGMENTS THE EFFICACY OF ANTI-CD20 MONOCLONAL ANTIBODIES BY UP-REGULATING CD20 LEVEL IN MALIGNANT B-CELLS

EHA Library, Malgorzata Bobrowicz, 53569

COMBINING ADOPTIVE TCR IMMUNOTHERAPY AND ARGININE DEPLETION IN OSTEOSARCOMA XENOGRAFT MODEL

EHA Library, Hakim Echchannaoui, 53568

CNS PROPHYLAXIS IN PATIENTS WITH DLBCL, ARE WE TREATING OURSELVES? A RESPONSE TO THE RECENT BCSH GUIDELINE.

EHA Library, Morag Griffin, 54408

OPTIMIZING TUMOR-REACTIVE SINGLE-CHAIN T CELL RECEPTORS FOR ADOPTIVE T CELL TRANSFER

EHA Library, Beate Hauptrock, 53567

ABNORMAL IMMUNOPHENOTYPE IS OF GREAT VALUE IN THE DIAGNOSIS OF AGGRESSIVE NATURAL KILLER CELL LEUKEMIA

EHA Library, Zhi-Yuan Qiu, 54407

FUNCTIONAL EVALUATION OF T-CELLS GENERATED FROM WT1-TCR TRANSDUCED HUMAN HEMATOPOIETIC STEM CELLS USING THE OP9-DL1 COCULTURE SYSTEM.

EHA Library, Tessa Kerre, 53566

RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOMES FOR 120 CASES OF NATURAL KILLER/T CELL LYMPHOMA, NASAL TYPE AT THE LARGEST SINGLE HOSPITAL OF NORTH-WESTERN CHINA

EHA Library, Rong Liang, 54406

NEXT-GENERATION DENDRITIC CELL VACCINATION AS POSTREMISSION THERAPY FOR AML PATIENTS WITH A NON-FAVORABLE RISK PROFILE

EHA Library, Felix Lichtenegger, 53565

DEFINING ACCURACY AND SENSITIVITY OF T-CELL RECEPTOR REPERTOIRE PROFILING FOR MONITORING RECURRENT/PERSISTENT DISEASE IN PATIENTS WITH MATURE T-CELL NEOPLASMS

EHA Library, Catherine Sanders, 54405

GENETIC CORRECTION OF DIFFERENTLY MOBILIZED HEMATOPOIETIC STEM CELLS FROM PATIENTS WITH THALASSEMIA AND ENGRAFTMENT KINETICS AFTER XENOTRANSPLANTATION

EHA Library, Garyfalia Karponi, 53564

COMBINING SEVERAL MOLECULAR ABNORMALITIES IN IDENTIFICATION OF HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA IMPROVES RISK-STRATIFICATION

EHA Library, Idun Fiskvik, 54404

VITAMIN D DEFICIENCY (VDD) IMPAIRS RITUXIMAB-MEDIATED CELLULAR CYTOTOXICITY AND OUTCOME OF DLBCL PATIENTS TREATED WITH, BUT NOT WITHOUT RITUXIMAB (R)

EHA Library, Viola Pöschel, 54403

ADOPTIVE TRANSFER OF RAPIDLY GENERATED EBV-CTLS FOR THE TREATMENT OF HIGH RISK ASSOCIATED EBV MALIGNANCIES

EHA Library, Serena Perna, 53562

BONE MARROW INVOLVEMENT AT DIAGNOSIS IS A POOR PROGNOSTIC FACTOR IN YOUNG PATIENTS WITH UNTREATED HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: SUB-ANALYSIS OF THE PHASE III RANDOMIZED FIL-DLCL04 TRIAL

EHA Library, Annalisa Chiappella, 54402

THE αβ-DNTS IN LYMPH NODES, BONE MARROW AND PERIPHERAL BLOOD OF LYMPHOMA PATIENTS: POTENTIAL PROGNOSTIC FACTOR OF CLINICAL OUTCOME.

EHA Library, Giacoma De Tullio, 53560

IN VITRO AND IN VIVO EFFECT OF ATO/IFN/AZT FOR ADULT T CELL LEUKEMIA/LYMPHOMA

EHA Library, Makoto Yoshimitsu, 54399

MIR-150 REGULATES IL-22-CCL20-CCR6 AUTOCRINE PATHWAY IN METASTATIC CUTANEOUS T- CELL LYMPHOMA

EHA Library, Kazuaki Teshima, 54398

COMPREHENSIVE CYTOGENETIC AND MOLECULAR GENETIC CHARACTERIZATION OF T-PLL

EHA Library, Anna Stengel, 54397

IMPACT OF CONSOLIDATION WITH BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTD) UPFRONT IN MULTIPLE MYELOMA (MM) WITH PARTIAL RESPONSE (PR) AT COMPLETION OF INDUCTION WITH VTD

EHA Library, Xavier Leleu, 53556

MICRORNA (MIRNA) EXPRESSION PROFILING IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TREATED WITH CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (CRD)

EHA Library, Andrzej J. Jakubowiak, 53555

ROLE AND RELATIONSHIP OF INTERLEUKIN-6 AND -15 IN T LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Antonella Teramo, 54395

OVERALL SURVIVAL OF PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: ADJUSTING FOR CROSSOVER IN THE MM-003 TRIAL FOR POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE

EHA Library, Gareth Morgan, 53554

SUBMICROSCOPIC GENOMIC REARRANGEMENTS CHANGE GENE EXPRESSION IN T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA

EHA Library, Katarzyna Izykowska, 54394

CYTOGENETICS AND LONG-TERM SURVIVAL IN MM-003, A PHASE 3 TRIAL OF POMALIDOMIDE + LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Meletios Dimopoulos, 53553

BACH2 SUPPRESSION IN CD4+ T CELLS MODULATES THEIR RESISTANCE TO APOPTOSIS DEMONSTRATING ITS FUNCTION AS A TUMOR SUPPRESSOR GENE

EHA Library, Vu Luan Dang Chi, 54393

PHASE 3 STUDY OF POMALIDOMIDE + LOW-DOSE DEXAMETHASONE VS. HIGH-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: MM-003 SUBANALYSIS OF ELDERLY PATIENTS (> 65 AND > 70 YEARS OF AGE)

EHA Library, Katja Weisel, 53552

THE RIZ1 GENE EXPRESSION IS SUPPRESSED IN T CELL LYMPHOMA AND THAT EXPRESSION IS CORRELATED WITH THE DECREASED GATA3 GENE EXPRESSION

EHA Library, Hanae Shimura, 54392

GENOME-WIDE DNA METHYLATION ANALYSIS REVEALS ACTIVATION OF WNT SIGNALING PATHWAY IN PERIPHERAL T-CELL LYMPHOMA-NOT OTHERWISE SPECIFIED

EHA Library, Xia Zhao, 54391

Exposure-safety-efficacy analysis of investigational oral ixazomib in relapsed/refractory multiple myeloma (MM): Phase 3 dose selection for maintenance post-autologous stem cell transplant

EHA Library, Neeraj Gupta, 53551

ISOLD: A VALUABLE SCORE TO DISCRIMINATE OCULAR LYMPHOMA FROM INFLAMMATORY DISEASES

EHA Library, Myrto Costopoulos, 54390

PANOBINOSTAT IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE (VPD) AS INDUCTION THERAPY IN PATIENTS WITH MULTIPLE MYELOMA CANDIDATES TO AUTOLOGOUS TRANSPLANT

EHA Library, SILVIA MANGIACAVALLI, 53550

WHOLE-BODY LOW-DOSE CT (WBLDCT) IS USEFUL FOR DETECTION, STAGING, RESPONSE EVALUATION AND FOLLOW-UP IN MYELOMA PATIENTS

EHA Library, Sara Pezzatti, 53549

BENDAMUSTINE AND PREDNISONE IN COMBINATION WITH BORTEZOMIB (BPV) IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED/UNTREATED MULTIPLE MYELOMA.

EHA Library, Wolfram Poenisch, 53548

COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS AND WHOLE GENOME SEQUENCING IN GERMINAL-CENTER DERIVED B-CELL LYMPHOMAS IN THE FRAMEWORK OF THE ICGC MMML-SEQ PROJECT

EHA Library, Cristina Lopez, 54388

HIGH-THROUGHPUT ANALYSIS OF FULL-LENGTH IMMUNOGLOBULIN TRANSCRIPTS BY TEMPLATE-SWITCHING ANCHORED PCR AND MASSIVE PARALLEL SEQUENCING ON THE PACBIO PLATFORM

EHA Library, Marvyn Koning, 54387

Effects of single-agent bortezomib as post-transplant consolidation on multiple myeloma-related bone disease: First results from a multicenter, randomized phase 2 study

EHA Library, Orhan Sezer, 53547

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: Subanalysis of patients with renal impairment in the phase 3 MMY-3021 study

EHA Library, Philippe Moreau, 53545

FIRST-LINE THERAPY FOR MULTIPLE MYELOMA (MM): RESULTS FROM THE SECOND INTERIM ANALYSIS OF THE REAL-WORLD, INTERNATIONAL, NON-INTERVENTIONAL EMMOS STUDY

EHA Library, Mohamad Mohty, 53544

A PROFILE OF 140 LONG-TERM SURVIVORS WITH SYSTEMIC AL AMYLOIDOSIS

EHA Library, Sajitha Sachchithanantham, 53543

INTRACELLULAR SIGNALING PATHWAYS IN HAIRY CELL LEUKEMIA (HCL) AND THEIR PROGNOSTIC RELEVANCE

EHA Library, Maria K Angelopoulou, 54383

IMPAIRED RHOA FUNCTION LEADS TO DEVELOPMENT OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Terukazu Enami, 54381

ANTI-TUMOR ACTIVITY OF SELINEXOR (KPT-330), AN ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE), ± DEXAMETHASONE IN MULTIPLE MYELOMA PRECLINICAL MODELS & TRANSLATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, CHRISTINE CHEN, 53540

TREATMENT OF ELDERLY PATIENTS WITH HODGKIN LYMPHOMA: EXPERIENCE OF A SINGLE UNIT

EHA Library, Francesca Pierdomenico, 54380

FREQUENT MUTATIONS IN PML-RARA IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Annette Fasan, 54133

NFATC1 MEDIATES SORAFENIB RESISTANCE IN FLT3-ITD POSITIVE ACUTE MYELOID LEUKEMIA

EHA Library, Andreas Burchert, 54134

EXPRESSION OF FLT3-ITD DYSREGULATES THE DBC1-SIRT1-P53 SIGNALING AND PROMOTES THERAPY RESISTANCE

EHA Library, Daniel Sasca, 54135

THE COMBINATION OF SELINEXOR (KPT-330), A SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE), & THE FLT3 INHIBITOR QUIZATINIB SHOWS ANTI-TUMOR ACTIVITY IN ACUTE MYELOID LEUKEMIA (AML) IN-VITRO AND IN-VIVO

EHA Library, CHRISTINE CHEN, 54136

CABOZANTINIB IS SELECTIVELY CYTOTOXIC IN ACUTE MYELOID LEUKEMIA CELLS WITH INTERNAL TANDEM DUPLICATION OF FLT3 (FLT3-ITD)

EHA Library, Liang-In Lin, 54137

PRE-CLINICAL ACTIVITY OF THE PI3K INHIBITOR BKM120 ON ACUTE MYELOID LEUKEMIA

EHA Library, Matteo Allegretti, 54138

THE CXCR4 ANTAGONIST BL-8040 SYNERGIZES WITH THE FLT3 INHIBITOR AC220 TO INDUCE APOPTOSIS AND REDUCE MINIMAL RESIDUAL DISEASE OF AML CELLS IN VIVO

EHA Library, Michal Abraham, 54139

VALIDATION OF BI-SPECIFIC T-CELL ENGAGER (BITE®) ANTIBODY ACTIVITY IN VITRO AND IN VIVO AGAINST DIFFERENTIALLY EXPRESSED CELL SURFACE TARGETS IN ACUTE MYELOID LEUKEMIA

EHA Library, Angus Sinclair, 54143

A NOVEL CLEC12AXCD3 BISPECIFIC ANTIBODY EFFICIENTLY INDUCES T-CELL MEDIATED LYSIS OF CLEC12A+ AML BLASTS

EHA Library, Basav Hangalapura, 54144

CELL-TO-CELL COMMUNICATION IN ACUTE MYELOID LEUKEMIA BY TUNNELING NANOTUBES

EHA Library, Maria Omsland, 54146

TIGAR COOPERATES WITH GLYCOLYSIS TO INHIBIT LEUKEMIA CELLS APOPTOSIS AND PREDICTS POOR PROGNOSIS IN PATIENTS WITH CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA

EHA Library, Sixuan Qian, 54147

GLYCOLYSIS INHIBITION ON ACUTE MYELOID LEUKEMIA

EHA Library, Simone Mirabilii, 54148

THE ROS/SUMO AXIS CONTRIBUTES TO ACUTE MYELOID LEUKEMIA CELL RESPONSE TO CHEMOTHERAPEUTIC DRUGS AND CONSTITUTES A POTENTIAL TARGET TO OVERCOME CHEMORESISTANCE

EHA Library, Guillaume Bossis, 54150

THE PROGNOSTIC RELEVANCE OF THE 2008 WHO CLASSIFICATION OF MYELOID NEOPLASMS IN CHILDHOOD ACUTE MYELOID LEUKEMIA

EHA Library, Akitoshi Kinoshita, 54152

REVISITING THE CLONAL DYNAMICS OF TRISOMY 21 AND MONOSOMY 7 MOSAICISM IN CONGENITAL NEUTROPENIA AML

EHA Library, Murat Ünalan, 54153

A SIMPLE AND EFFECTIVE STRATEGY TO DECREASE EARLY DEATHS IN ACUTE PROMYELOCYTIC LEUKEMIA USING A STREAMLINED SET OF GUIDELINES PAIRED WITH EXPERT SUPPORT.

EHA Library, Anand Jillella, 54154

INCIDENCE AND TYPE OF IDH1 AND IDH2 MUTATIONS IN AML-NK PATIENTS AND THEIR PROGNOSTIC IMPACT ON TREATMENT OUTCOME

EHA Library, Hyeougn-Joon Kim, 54155

THE PROGNOSTIC IMPACT OF CYTOGENETIC AND GENETIC ABNORMALITY FOR THE ACHIEVEMENT OF THE SECOND COMPLETE REMISSION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA.

EHA Library, Keiko Fukunaga, 54159

PSEUDO-EXHAUSTION OF T CELLS IN RELAPSED AML

EHA Library, Felix Lichtenegger, 54131

CD123 (IL-3R?) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION

EHA Library, Lorenzo Brunetti, 54128

ANALYSIS OF NPM1 SPLICE VARIANTS REVEALS DIFFERENTIAL EXPRESSION PATTERNS OF PROGNOSTIC VALUE IN ACUTE MYELOID LEUKEMIA

EHA Library, Malgorzata Zajac, 54126

THE PROGNOSTIC VALUE OF LEUKEMIC STEM CELLS IN PEDIATRIC AML.

EHA Library, Bram De Caluwé, 54129

GSX2 DEREGULATION IN CD7+ ACUTE MYELOID LEUKEMIA BEARING 4Q12 TRANSLOCATIONS WITHOUT FUSION GENES

EHA Library, Danika Di Giacomo, 54122

CHARACTERIZATION OF THE RARE TRANSLOCATION T(3;10)(Q26;Q21) IN AN ACUTE MYELOID LEUKEMIA PATIENT

EHA Library, Tereza Jancuskova, 54121

DECREASE EXPRESSION OF MIR-20A PROMOTES CANCER CELL PROLIFERATION AND PREDICTS POOR SURVIVAL OF ACUTE MYELOID LEUKEMIA

EHA Library, Zhang Nan, 54119

ENDOCRINE SIDE EFFECTS AFTER CHEMOTHERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yesim Oymak, 54117

LENALIDOMIDE FOR TREATMENT OF REFRACTORY/RELAPSED ADULT B-ALL PATIENTS: RESULTS OF A MULTICENTRIC PHASE 2 STUDY.

EHA Library, Tavernier-Tardy Emmanuelle, 54116

MOLECULAR CYTOGENETIC ANALYSIS IN 108 CHILDHOOD ACUTE LEUKEMIA PATIENTS FROM SAUDI ARABIA: CORRELATION TO MOLECULAR AND OTHER BIOLOGIC FACTORS

EHA Library, Yasser Elborai, 54115

ASPARAGINASE-ASSOCIATED PANCREATITIS (AAP) DURING TREATMENT FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

EHA Library, Teresa Garrido, 54114

INVASIVE FUNGAL INFECTIONS IN PEDIATRIC PATIENTS WITH ACUTE LEUKEMIA: RESULTS FROM AN UNIVERSITY HOSPITAL, 2005 TO 2013

EHA Library, Zumrut Sahbudak Bal, 54113

RELATIONSHIP BETWEEN MTHFR POLYMORPHISM AND SIDE EFFECTS OF HIGH-DOSE METHOTREXATE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Seham Ragab, 54110

QUANTITATIVE ULTRASOUND OF PROXIMAL PHALANXES IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA SURVIVORS

EHA Library, Antonia De Matteo, 54109

TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLO-HSCT BY SALVAGE CHEMOTHERAPY WITH LOW-DOSE CYTARABINE AND ACLARUBICIN COMBINED WITH G-CSF PRIMING: MORE EFFECTIVE AND LESS TOXIC?

EHA Library, Depei Wu, 54108

FREQUENCY AND CLINICAL SIGNIFICANCE OF OCCULT CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS

EHA Library, Jordi Vila-Bou, 54107

6-MERCAPTOPURINE DOSAGE REDUCTION AND TPMT POLYMORPHISMS IN THE TREATMENT OF CHILDREN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ana Ferreira Baptista, 54106

AUTOPHAGY INDUCED BY DEXAMETHASONE MEDIATES GLUCOCORTICOID RESISTANCE IN LYMPHOID MALIGNANCY CELLS

EHA Library, Lei Jiang, 54102

A COMPREHENSIVE NEW DNA TEST FOR DETECTION OF FUSION GENES IN LEUKEMIA

EHA Library, Eva Van Den Berg-De Ruiter, 54101

IMMUNE STATUS IN RELATION TO THE TREATMENT OF CHILDHOOD BCP-ALL ACCORDING TO THE NOPHO ALL2008 PROTOCOL

EHA Library, Bibi Fatima Syed Shah, 54100

SIGNIFICANCE OF ADDITIONAL STRUCTURAL ABERRATIONS IN BONE MARROW CELLS OF 115 CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND HIGH HYPERDIPLOIDY

EHA Library, Libuse Lizcova, 54099

CD20 EXPRESSION IN ADULTS WITH PRECURSOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) FROM UKALL14, ITS REGULATION BY DEXAMETHASONE AND RITUXIMAB INDUCED CYTOTOXICITY

EHA Library, Brendan Beaton, 54094

THE DIFFERENCE OF RCSD1-ABL1-LEUKEMOGENICITY BETWEEN EXON3 OF RCSD1/EXON 4 OF ABL1 AND EXON 2 OF RCSD1/EXON 4 OF ABL1

EHA Library, Hayato Tamai, 54093

COMPLEX GENETIC HETEROGENEITY INFLUENCES PROGNOSIS IN ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA NEGATIVE FOR RECURRENT FUSION GENES

EHA Library, Ilaria Iacobucci, 54088

TARGETING THE DOPAMINE RECEPTOR SIGNALING REDUCES THE POLYCOMB PROTEIN BMI1 AND LIMITS THE SELF-RENEWAL OF BCR-ABL1 POSITIVE LEUKEMIA CELLS

EHA Library, Tetsuzo Tauchi, 54087

DEVELOPMENT OF MOLECULAR BEACON BASED PCR ASSAY FOR EASY DETECTION AND QUANTIFICATION OF CHIMERIC TRANSCRIPTS OF AML-ETO [T(8;21)] IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Rashi Arora, 54125